PE targets opportunities in nutraceuticals: 7 deals

Published on August 14, 2026

Butterfly Equity, Gryphon Investors, Frontenac and Wise Equity are targeting platforms in the nutraceuticals sector.

The post PE targets opportunities in nutraceuticals: 7 deals appeared first on PE Hub.